Lung Cancer Mortality Risk Predicted by Blood Test
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read MorePosted by Chris Wolski | Jun 30, 2023 | Lung Cancer |
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read MorePosted by Chris Wolski | Jun 30, 2023 | Prostate |
Cleveland Diagnostics, a biotechnology company developing next-gen diagnostic tests for early detection of cancers, opened a new facility.
Read MorePosted by Melanie Hamilton-Basich | Jun 9, 2023 | Prostate |
American Indian and Alaska Native men also experience disproportionately greater prostate cancer mortality compared to other racial/ethnic identities.
Read MorePosted by Melanie Hamilton-Basich | Jun 6, 2023 | Cancer, Sequencing Systems |
The study’s multi-cancer early detection data show Exai’s RNA- and AI-based platform can detect multiple cancer types at the earliest stages using a single, standard blood sample.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Prostate |
The accuracy of PSA in prostate cancer screening can be improved by accounting for genetic factors that are not associated with cancer.
Read More